Brain natriuretic peptide (BNP) level at enrolment predicts 1- and 5-year transplant-free survival in patients with pulmonary arterial hypertension (PAH): data from the REVEAL registry

Back

ESC Premium Access

Brain natriuretic peptide (BNP) level at enrolment predicts 1- and 5-year transplant-free survival in patients with pulmonary arterial hypertension (PAH): data from the REVEAL registry

Session: Pulmonary hypertension: diagnosis, functional imaging and molecular phenotyping

Topic: Chronic pulmonary hypertension

Speaker: Doctor R. Frantz (Rochester, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Robert Frantz

Mayo Clinic, Rochester (United States of America)

0 follower

8 more presentations in this session

Severe ventricular interdependence as a cause of misclassification of group 2 pulmonary hypertension

Speaker: Doctor S. Rosset (Lausanne, CH)

Pulmonary hypertension and pregnancy outcomes: data from the ropac study of the european society of cardiology

Speaker: Doctor I. van Hagen (Rotterdam, NL)

Left and right ventricular peak filling rates are reduced in patients with pulmonary arterial hypertension measured with magnetic resonance imaging

Speaker: Doctor C. Goransson (Malmo, SE)

Peak oxygen uptake during exercise is able to exclude scleroderma-associated pulmonary arterial hypertension with a high probability

Speaker: Doctor D. Dumitrescu (Bad Oeynhausen, DE)

Right ventricular function in acute and chronic pulmonary hypertension using exercise cardiac magnetic resonance imaging

Speaker: Doctor S. Jaijee (London, GB)

Access the full session

Pulmonary hypertension: diagnosis, functional imaging and molecular phenotyping

Speakers: Doctor R. Frantz, Doctor S. Rosset, Doctor I. van Hagen, Doctor C. Goransson, Doctor D. Dumitrescu...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources